These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6171081)

  • 1. [Peroral analgetic treatment with a methadone mixture in terminal cancer patients].
    Madsen OG; Christoffersen I; Philbert A
    Ugeskr Laeger; 1981 Jun; 143(25):1591-5. PubMed ID: 6171081
    [No Abstract]   [Full Text] [Related]  

  • 2. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study.
    Fisher K; Stiles C; Hagen NA
    J Pain Symptom Manage; 2004 Dec; 28(6):619-25. PubMed ID: 15589088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-lasting pain relief with rectal methadone therapy].
    Paalzow L; Andersson B; Lööf G; Kullman S; Andersson B
    Lakartidningen; 1983 Jan; 80(3):114-6. PubMed ID: 6190051
    [No Abstract]   [Full Text] [Related]  

  • 6. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peroral morphine treatment of pain in terminal cancer].
    Kager L; Ljungdahl I; Rane A; Säwe J
    Lakartidningen; 1979 Oct; 76(40):3411-5. PubMed ID: 91722
    [No Abstract]   [Full Text] [Related]  

  • 8. Opioid-sparing effect of diclofenac in cancer pain.
    Mercadante S; Sapio M; Caligara M; Serretta R; Dardanoni G; Barresi L
    J Pain Symptom Manage; 1997 Jul; 14(1):15-20. PubMed ID: 9223838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist intervention in methadone administration to cancer patients with chronic pain.
    Powers DA; Hamilton CW; Roberts KB
    Am J Hosp Pharm; 1983 Sep; 40(9):1520-3. PubMed ID: 6624755
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid rotation to methadone at home.
    Hernansanz S; Gutiérrez C; Rubiales AS; Flores LA; del Valle ML
    J Pain Symptom Manage; 2006 Jan; 31(1):2-4. PubMed ID: 16442475
    [No Abstract]   [Full Text] [Related]  

  • 11. Consensus guideline on parenteral methadone use in pain and palliative care.
    Shaiova L; Berger A; Blinderman CD; Bruera E; Davis MP; Derby S; Inturrisi C; Kalman J; Mehta D; Pappagallo M; Perlov E
    Palliat Support Care; 2008 Jun; 6(2):165-76. PubMed ID: 18501052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone: an effective alternative to morphine for pain relief in cancer patients.
    Shelton BW; Deynes-Romero J; Tofani-Montalvo M; Ramírez-Rivera J; Jaumne-Anselmi F
    Bol Asoc Med P R; 2008; 100(3):7-10. PubMed ID: 19227708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes.
    Reddy S; Fisch M; Bruera E
    J Pain Symptom Manage; 2004 Oct; 28(4):301-3. PubMed ID: 15471646
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing methadone, a unique analgesic.
    Manfredi PL; Houde RW
    J Support Oncol; 2003; 1(3):216-20. PubMed ID: 15334878
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
    Auret K; Roger Goucke C; Ilett KF; Page-Sharp M; Boyd F; Oh TE
    Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone treatment of chronic non-malignant pain and opioid dependence--a long-term follow-up.
    Rhodin A; Grönbladh L; Nilsson LH; Gordh T
    Eur J Pain; 2006 Apr; 10(3):271-8. PubMed ID: 15972261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trial of tiapride as an analgesic in cancer patients ].
    Le Derff H
    Sem Hop; 1982 Jul; 58(28-29):1708-11. PubMed ID: 6181565
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.